Filing Details
- Accession Number:
- 0001209191-20-057329
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 17:37:39
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-06 17:37:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1244921 | N Jeffrey West | 14100 Magellan Plaza Maryland Heights MO 63043 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2020-11-04 | 1,298 | $68.50 | 24,313 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2020-11-04 | 1,183 | $66.57 | 25,496 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Disposition | 2020-11-04 | 2,481 | $80.00 | 23,015 | No | 4 | S | Direct | |
Ordinary Common Stock, $0.01 Par Value | Disposition | 2020-11-04 | 139 | $80.00 | 22,876 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2020-11-04 | 1,298 | $0.00 | 1,298 | $68.50 |
Common Stock | Stock Options (right to buy) | Disposition | 2020-11-04 | 1,183 | $0.00 | 1,183 | $66.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-03-03 | No | 4 | X | Direct | |
2,365 | 2029-03-02 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $80.0005. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- All of the stock options in this tranche have vested in full.
- Not applicable.
- Of the 3,548 stock options in this tranche, 1,183 vested on March 3, 2020 and have been exercised as of the date of reporting. The remainder of 2,365 stock options shall vest in equal increments on March 3, 2021 and 2022.